ArticleAsian journal of pharmaceutical sciences2026
Engineered GLUT1-targeted STING polyproagonists: Redox-triggered activation and enhanced endosomal escape for cancer immunotherapy.
Arsalan Raza et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.